About us
Team
Supervisory Board
Scientific Advisory Board
Clinical Advisors
Technology
Pipeline
Investors
Career
News & Events
Contact us
Menu
About us
Team
Supervisory Board
Scientific Advisory Board
Clinical Advisors
Technology
Pipeline
Investors
Career
News & Events
Contact us
About us
Team
Supervisory Board
Scientific Advisory Board
Clinical Advisors
Technology
Pipeline
Investors
Career
News & Events
Contact us
About us
Team
Supervisory Board
Scientific Advisory Board
Clinical Advisors
Technology
Pipeline
Investors
Career
News & Events
Contact us
Imprint
Privacy Statement
Disclaimer
Imprint
Privacy Statement
Disclaimer
News & Events
News
Our latest Press Releases
Tubulis partners TUB-010 its CD30-targeting IND-ready ADC with Oncoteq
November 27, 2023
Tubulis publishes article in Molecular Cancer Therapeutics on advantages of its proprietary P5/Tubutecan platform
October 17, 2023
Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients
April 20, 2023
More News
EVENTS
Meet Tubulis live
Presentation
,
Talk
ADC Linker & Conjugation Summit, Boston
August 22 – August 24
Presentation
Festival of Biologics, Basel
October 10 – October 12
Poster
World ADC, San Diego
October 16 – October 19
Event
ESMO Congress, Madrid
October 20 – October 24
Partnering
Bio Europe, Munich
November 6 – November 8
Partnering
J.P. Morgan 42nd Conference, San Francisco
January 8 – January 11
More Events